December 10, 2024
CMIC Group
CMIC Group is pleased to announce that it has been selected as the Winner in the “Leadership in Regulatory Compliance” category of the Fierce CRO Awards 2024
The Fierce CRO Awards are open to CROs of all sizes and specialties in the life sciences industry. The judging criteria are innovation and impact, results, sustainability and scalability, and ethics and regulatory compliance. The “Leadership in Regulatory Compliance” category recognizes CROs that demonstrate exemplary efforts in adhering to regulatory standards and guidelines, ensuring compliance and facilitating smooth regulatory submissions.
The reasons for this award include “our in-house training system for acquiring the regulatory and compliance knowledge required at every phase of clinical development,” “our strategic consulting for smooth and speedy drug applications provided by more than 180 pharmaceutical consulting and medical writing experts, including support for Cartagena applications and ODD (Orphan Drug Designation) designation, the largest in Japan,” and “our track record and experience in supporting entry into the Japanese market as an ICCC (In-Country Clinical Caretaker).”
For the full Fierce CRO Awards 2024 report, click here.
CMIC Group will continue to make efforts to create and provide new value in the healthcare industry by utilizing the extensive experience and know-how it has cultivated thus far.
View CMIC Group’s Awards: https://en.cmicgroup.com/insights/company-awards/
